Evidence map›Paper›PMID 28671140›Full record

ArticleJournal of Parkinson's disease2017

A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement.

Paul de Roos, Bastiaan R Bloem, Thomas A Kelley, Angelo Antonini, Richard Dodel, Peter Hagell, Connie Marras, Pablo Martinez-Martin, Shyamal H Mehta, Per Odin and 4 more

Registry-linked trialAbstract readConsensus Statement
In one paragraph

Article in Journal of Parkinson's disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05343962 (Observational Study for the Identification of Relevant Variables Related to Health Status, Disability and Quality in Different Populations, Through the Analysis of Health Determinants and Paremeters Obtained by Means of Patient-reported Outcomes Questionnaires.), which is not on this map. Cited by 33 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05343962 unknown statusnot on this mapstarted 2022, after this paper: background citation

Observational Study for the Identification of Relevant Variables Related to Health Status, Disability and Quality in Different Populations, Through the Analysis of Health Determinants and Paremeters Obtained by Means of Patient-reported Outcomes Questionnaires.

TypeobservationalSponsorInstituto de Biomecanica de ValenciaRan2022 to 2023Enrolled250ConditionsParkinson Disease, Diabetes Mellitus, COVID-19, Chronic Obstructive Pulmonary Disease (COPD)
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Treatment of Dysphagia in Parkinson's Disease: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Measuring What Matters in Parkinson's Disease Research and Dysphagia: The Need for Core Outcome Sets.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  12. Article
  13. Frontiers in sports and active living · 2025
    Article
  14. Outcome Selection for Research Studies in Movement Disorders.Movement disorders clinical practice · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paul de RoosDepartment of Neuroscience, Neurology, Uppsala University, Uppsala, Sweden.
Bastiaan R BloemRadboud University Medical Center; Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Nijmegen, The Netherlands.
Thomas A KelleyInternational Consortium for Health Outcomes Measurement, Cambridge, USA.
Angelo AntoniniDepartment of Neuroscience (DNS), Padova University, Padova, Italy; Fondazione Ospedale San Camillo-I.R.C.C.S., Parkinson and Movement Disorders Unit, Venice, Italy.
Richard DodelPhilipps-Universitat, Marburg, Germany.
Peter HagellThe PRO-CARE Group, School of Health and Society, Kristianstad University, Kristianstad, Sweden.
Connie MarrasMorton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, Canada.
Pablo Martinez-MartinNational Center of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
Shyamal H MehtaMayo Clinic, Scottsdale, USA.
Per OdinSkåne University Hospital, Lund, Sweden.
Kallol Ray ChaudhuriKing's College, London, UK.
Daniel WeintraubPerelman School of Medicine at the University of Pennsylvania, Philadelphia, USA.
Bil WilsonICHOM Patient Representative, USA.
Ryan J UittiMayo Clinic, Jacksonville, FL, USA.

Funding

Project IV: "Alpha-Synuclein Strains & Diverse Synucleinopathies"P50NS053488 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI TROJANOWSKI, JOHN Q. · 2007 to 2017
$20.9M
NINDS NIH HHS P50 NS053488
6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is a progressive neurodegenerative condition that is expected to double in prevalence due to demographic shifts. Value-based healthcare is a proposed strategy to improve outcomes and decrease costs. To move towards an actual value-based health care system, condition-specific outcomes that are meaningful to patients are essential.

objectivePropose a global consensus standard set of outcome measures for PD.

methodsEstablished methods for outcome measure development were applied, as outlined and used previously by the International Consortium for Health Outcomes Measurement (ICHOM). An international group, representing both patients and experts from the fields of neurology, psychiatry, nursing, and existing outcome measurement efforts, was convened. The group participated in six teleconferences over a six-month period, reviewed existing data and practices, and ultimately proposed a standard set of measures by which patients should be tracked, and how often data should be collected.

resultsThe standard set applies to all cases of idiopathic PD, and includes assessments of motor and non-motor symptoms, ability to work, PD-related health status, and hospital admissions. Baseline demographic and clinical variables are included to enable case mix adjustment.

conclusionsThe Standard Set is now ready for use and pilot testing in the clinical setting. Ultimately, we believe that using the set of outcomes proposed here will allow clinicians and scientists across the world to document, report, and compare PD-related outcomes in a standardized fashion. Such international benchmarks will improve our understanding of the disease course and allow for identification of 'best practices', ultimately leading to better informed treatment decisions.

Indexed as

Outcome Assessment, Health CareFemaleHealth StatusHumansMaleParkinson DiseaseSocieties, MedicalTreatment OutcomeActivities of Daily LivingAgedDelivery of Health Care*/economicsDelivery of Health Care*/standardsDisability EvaluationDisease ProgressionEfficiencyFemaleHealth Care Costs Health StatusHealth Care/standardsHealth SurveysHealth Surveys/Health Status IndicatorsHumansInternational CooperationMaleMiddle AgedOrganizationalOutcome and Process Assessment (Health Care)/standardsOutcome Assessment (Health Care)Parkinson DiseaseParkinson Disease/epidemiologyParkinson Disease/therapy*Parkinsonian DisordersPsychometricsQuality IndicatorsQuality of Health CareQuality of Life

Identifiers

PMID28671140
PMCPMC5685544

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.